Vol.

No.

July 12, 2019Jul 12, 2019

DOWNLOAD THE PDF

Cover Story

Wistar and Christiana Care seek NCI recognition of their unique alliance

The relationship between The Wistar Institute Cancer Center and Christiana Care's Helen F. Graham Cancer Center and Research Institute is unlike any other.

Conversation with The Cancer Letter

Petrelli and Altieri plan to ask NCI to rethink the “five-and-seven rule” for consortia

By Paul Goldberg

Medicaid should pay for patients to enroll in clinical trials, coalition tells Congress

By Claire Dietz

Clinical Conversation with The Cancer Letter Free

Curtis: Women are intrigued by the many questions asked in TMIST

By Paul Goldberg

In Brief

Emory Winship Cancer Institute awarded NCI lung cancer SPORE grant

Sparano to receive William L. McGuire Memorial Lecture Award

Multiple Myeloma Research Foundation launches two initiatives

Darr named associate director of administration at UNC Lineberger

ACCC partners with AstraZeneca, Merck to launch ovarian cancer initiative

Wistar Institute receives $4.2M in philanthropic support

Beachy receives 2019 Bladder Cancer Research Innovation award

Thibodeau named COO of OncoCell MDx

Recipients of the Presidential Early Career Award for scientists and engineers announced

Friedman named chief scientific officer at ORIC Pharmaceuticals

Funding Opportunities

Why cancer innovation must go beyond medicine: The C3 Prize search for ideas with the greatest potential for impact

Clinical Roundup

Triplet-targeted therapy improves survival in colorectal cancer

Trial demonstrates efficacy of flexible dose of regorafenib in colon cancer

UCI team pioneers bone sparing cancer treatment targeting bone metastases

Drugs & Targets

FDA approves expanded indication for FoundationOneCDx as a companion diagnostic for Lynparza

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues